100 Results

People

  1. Horwitz
    Horwitz
  2. Moskowitz
    Moskowitz
  3. Derkach
    Derkach
  4. Dogan
    Dogan
  5. Matasar
    Matasar
  6. Noy
    Noy
  7. Giralt
    Giralt
  8. Hamlin
    Hamlin
  9. Palomba
    Palomba
  10. Zelenetz
    Zelenetz

Groups

  1. Department of Medicine (100)
  2. Hematologic Malignancies, Division of (100)
  3. Population Sciences Research Program (100)
  4. Center for Hematologic Malignancies (84)
  5. Lymphoma (55)
  6. Survivorship Research (51)
  7. Epidemiology and Biostatistics (49)
  8. Biostatistics Service (44)
  9. Sloan Kettering Institute Postdocs (42)
  10. CTCR Scholars (28)
  1. "2020"
  2. "Hematologic Malignancies, Division of"
  3. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (50)
  2. Journal Article (43)
  3. Guidelines (2)
  4. Research Letter (2)
  5. Book Section (1)
  6. Correspondence (1)
  7. Review (1)
Groups
  1. Department of Medicine (100)
  2. Hematologic Malignancies, Division of (100)
  3. Population Sciences Research Program (100)
  4. Center for Hematologic Malignancies (84)
  5. Lymphoma (55)
  6. Survivorship Research (51)

More Groups

People
  1. Steven Horwitz (52)
  2. Alison Moskowitz (24)
  3. Ahmet Dogan (23)
  4. Andriy Derkach (16)
  5. David Straus (13)
  6. Matthew Matasar (13)

More People

Years
  1. 2020 (100)
Publications
  1. Blood (28)
  2. Journal of Clinical Oncology (13)
  3. Blood Advances (5)
  4. Leukemia and Lymphoma (4)
  5. Blood Cancer Journal (3)
  6. Clinical Lymphoma, Myeloma and Leukemia (3)

More Publications

Publishers
  1. American Society of Hematology (33)
  2. American Society of Clinical Oncology (14)
  3. Elsevier Inc. (8)
  4. Nature Publishing Group (6)
  5. American Association for Cancer Research (5)
  6. Taylor & Francis Group (5)

More Publishers

Results (100)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • COVID-19 infections and clinical outcomes in patients with multiple myeloma in New York City: A cohort study from five academic centers
    Journal Article

    Hultcrantz, M.; Richter, J.; Rosenbaum, C. A.; Patel, D.; Smith, E. L.; Korde, N.; Lu, S. X.; Mailankody, S.; Shah, U. A.; Lesokhin, A. M.; more...
    Blood Cancer Discovery (2020)

    Fulltext@MSK | Save
  • VRd versus KRd safety profiles in newly diagnosed multiple myeloma patients using real-world evidence data from a single institution: VRd has high rates of chronic neuropathy, and KRd has low rates of cardiopulmonary or renal toxicities when using optimized IV fluid management coupled with baseline cardiac workup
    Meeting Abstract

    Tan, C.; Diamond, B.; Hultcrantz, M.; Korde, N.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; Lu, S. X.; Patel, D.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J. L.; King, A. C.; Daniyan, A.; Famulare, C.; Cuello, B. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders: A population based study including 94,579 cases and 368,348 matched controls
    Meeting Abstract

    Shah, U. A.; Rögnvaldsson, S.; Derkach, A.; Björkholm, M.; Turesson, I.; David, Y.; Hultcrantz, M.; Tan, C.; Hassoun, H.; Korde, N.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Multi-center phase II study of oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    Ruan, J.; Moskowitz, A. J.; Mehta-Shah, N.; Sokol, L.; Chen, Z.; Rahim, R.; Song, W.; Van Besien, K.; Horwitz, S. M.; Rutherford, S. C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Favorable outcomes among patients with T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era
    Meeting Abstract

    Robin, E. T.; Drill, E.; Batlevi, C. L.; Caron, P.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; Joffe, E.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Duvelisib in patients with relapsed/refractory peripheral T-cell lymphoma from the phase 2 primo trial: Dose optimization efficacy update and expansion phase initial results
    Meeting Abstract

    Pro, B.; Brammer, J. E.; Casulo, C.; Jacobsen, E.; Mead, M.; Mehta-Shah, N.; Zain, J. M.; Zinzani, P. L.; Lustgarten, S.; Youssoufian, H.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals evidence of two biologically and clinically distinct entities: Progressive versus stable myeloma precursor disease
    Meeting Abstract

    Oben, B.; Froyen, G.; Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Abascal, F.; Leongamornlert, D. A.; Derkach, A.; Geerdens, E.; Diamond, B.; more...
    Blood (2020)

    Fulltext@MSK | Save